Targeting lung fibrosis: from bench to bedside

Symposium
Chairs: T. Tetley (London, United Kingdom), D. Weiss (Burlington, United States of America)
Aims: During the session, the audience will learn about new approaches for treating idiopathic pulmonary fibrosis (IPF).

Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials D. Chambers (Brisbane, Australia)
Stem cell therapy in IPF D. Bouros (Alexandroupolis, Greece)
Mesenchymal stem cells and fibrotic lung diseases M. Rojas (Pittsburgh, United States of America)